Novel therapy based on camelid nanobodies

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Immunology and Molecular Medicine

Background:

• Nanobodies (Nbs) are antigen-binding fragments derived from heavy-chain-only camelid antibodies.
• They possess unique physicochemical properties, including small size, high stability, and good solubility.
• Their potential for humanization and specific antigen recognition makes them attractive for therapeutic applications.

Purpose of the Study:

• To provide a comprehensive overview of camelid-derived nanobodies (Nbs) as therapeutic agents.
• To highlight the current state of Nb development for treating various diseases.
• To explore the potential of Nbs in targeted delivery of biologically active components.

Main Methods:

• Review of current scientific literature on nanobody research and development.
• Analysis of therapeutic approaches utilizing camelid-derived nanobodies.
• Synthesis of information on the application of Nbs across different disease areas.

Main Results:

• Nanobodies are effective in developing targeted therapies due to their unique properties.
• Therapeutic strategies using Nbs are being explored for immune, bone, blood, and neurological disorders.
• Nbs show potential in treating infectious diseases and various forms of cancer.

Conclusions:

• Camelid-derived nanobodies represent a promising class of novel therapeutic agents.
• Their versatility supports applications in targeted drug delivery and treatment of a wide spectrum of diseases.
• Further research and development are expected to expand the therapeutic utility of nanobodies.